IP Library Granted Patent US 9,611,497
Granted Patent B2
US 9,611,497 · App. 13/463,624 · Granted Apr 4, 2017

Crude biological derivatives competent for nucleic acid detection

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,611,497
App. No.
13/463,624
Granted
Apr 4, 2017
Kind
B2
Abstract

The invention relates to methods for the detection of a specific sequence of RNA in a cell or tissue sample. The invention also relates to methods to enzymatically manipulate the RNA in a crude cell lysate in a number of applications.

Claims (22)

1. A method for measuring a level of RNA in a sample of cells using real time PCR, the method comprising:

preparing an admixture of the sample, a proteinase K and a deoxyribonuclease, wherein the concentration of cells in the admixture is up to 2500 cells per μl;

incubating the admixture under conditions where the proteinase K and the deoxyribonuclease are active to produce a cell lysate;

incubating the cell lysate at a temperature up to about 75° C. wherein the proteinase K and the deoxyribonuclease are inactivated;

incubating a volume of cell lysate with at least one reverse transcriptase under conditions to allow reverse transcription to produce cDNA,

amplifying the cDNA using real-time PCR to produce amplified cDNA,

measuring the amount of amplified cDNA, and

calculating the level of RNA based on the measured amount of amplified cDNA.

2. The method of claim 1 , wherein the cells are eukaryotic cells.

3. The method of claim 2 , wherein the eukaryotic cells are human cells.

4. The method of claim 1 , wherein the cells are obtained from a cell culture.

5. The method of claim 1 , wherein incubating with reverse transcriptase and amplifying the cDNA provide for one-step RT-PCR.

6. The method of claim 1 , wherein the cells are obtained from a subject.

7. The method of claim 1 wherein the concentration of cells in the admixture is from 4 cells/μl to 2500 cells/μl.

8. A method for measuring a level of RNA in a sample of cells using real time PCR, the method comprising:

preparing an admixture of the sample, a proteinase K and a deoxyribonuclease, wherein the concentration of cells in the admixture is up to 2500 cells per μl;

incubating the admixture under conditions where the proteinase K and the deoxyribonuclease are active to produce a cell lysate;

incubating the cell lysate at a temperature up to about 75° C. wherein the proteinase K and the deoxyribonuclease are inactivated;

incubating a volume of cell lysate with at least one reverse transcriptase under conditions to allow reverse transcription to produce cDNA,

amplifying the cDNA using real-time PCR to produce amplified cDNA,

measuring the amount of amplified cDNA, and

calculating the level of RNA based on the measured amount of amplified cDNA wherein the cells are obtained from a sample of body fluid.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2012
From: PASLOSKE, BRITTAN L
To: AMBION, INC.
Reel/Frame 029460/0975 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2012
From: AMBION, INC.
To: APPLERA CORPORATION
Reel/Frame 029461/0060 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2012
From: HOANG, QUOC
To: APPLERA CORPORATION
Reel/Frame 029461/0111 →
MERGER Recorded Dec 13, 2012
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 029461/0147 →
MERGER Recorded Dec 13, 2012
From: ATOM ACQUISITION CORPORATION; APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 029461/0179 →
MERGER Recorded Dec 13, 2012
From: ATOM ACQUISITION CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 029461/0203 →